Stem Cell in Acute Myocardial Infarction

Summary

The study will perform UC-MSCs transplantation in 2 groups and 1 control group with standard treatment. Each group consists of 5 subjects. In the first group UC-MSCs will be transplanted via intravenous (IV) route and the second group via intracoronary (IC) route. The IV group will receive 2 million cells/kg for each subject and the dosage of IC group is 50 million cells for each subject. All groups will be observed until 1 year.

Timeline

Start

2019-03-11

Primary completion

2021-04-08

Completion

2022-04-08

Drugs

Indications